1361 Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer

1361 Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer

Bibliographic Details
Main Authors:	Li Zhang, Lawrence Fong, Andrew H Ko, Brandon Chen, Alexander Cheung, Alec Starzinski, Hai Yang, Tony Li, Bridget P Keenan, Maira Soto, Erin L Filbert, Stephanie Starzinski, Marissa Gin, Phi Le, Brandon Bol, Frank J Hsu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

862 TLR9 agonism promotes cytotoxic T cell persistence and myeloid remodeling when combined with radiation therapy and PD-1 blockade in oligometastatic prostate cancer patients
by: Li Zhang, et al.
Published: (2023-11-01)

Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
by: Xiao Liu, et al.
Published: (2024-04-01)

Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
by: M. Usman Ahmad, et al.
Published: (2022-03-01)

Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?
by: Eric Zandirad, et al.
Published: (2022-11-01)

O clero e as Cortes de 1361
by: Hermínia Vasconcelos Vilar
Published: (2020-07-01)

548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progression
by: Lawrence Fong, et al.
Published: (2023-11-01)

Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
by: Attila Paszt, et al.
Published: (2023-04-01)

The incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer
by: Rune B Strandby, et al.
Published: (2020-01-01)

Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review
by: Jincheng Wang, et al.
Published: (2024-01-01)

Surgical management of cancer of the stomach and gastroesophageal junction after neoadjuvant therapy: the experience of the MRRC and literature review
by: V. Yu. Skoropad, et al.
Published: (2023-02-01)

Dedifferentiated Liposarcoma of the Gastroesophageal Junction
by: Gökçe AŞKAN, et al.
Published: (2018-01-01)

Neoadjuvant radiotherapy for locoregional Siewert type II gastroesophageal junction adenocarcinoma: A propensity scores matching analysis.
by: Yuan Zhou, et al.
Published: (2021-01-01)

The Evolving Landscape of Neoadjuvant Immunotherapy in Gastroesophageal Cancer
by: Colum Dennehy, et al.
Published: (2024-01-01)

Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials
by: Jie Zhu, et al.
Published: (2022-12-01)

Surgical Treatment of Patients with Adenocarcinoma of the Distal Esophageal Portion and Gastroesophageal Junction Performed After Neoadjuvant Chemotherapy and Combined Chemoradiation
by: Yankov G., et al.
Published: (2022-04-01)

“The First Wave”: The Shibanid dominance in the Lower Volga region in 1361–1367
by: Grinberg M.
Published: (2022-06-01)

A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma
by: Jin-Ming Shi, et al.
Published: (2024-03-01)

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
by: Zhaoqing Tang, et al.
Published: (2022-11-01)

Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010-12-01)

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma
by: Yuki Hirata, et al.
Published: (2023-10-01)

A patient with gastroesophageal junction carcinoma and cough
by: Priyanka S Makkar, et al.
Published: (2021-01-01)

Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells
by: Katharina Hötte, et al.
Published: (2017-06-01)

Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
by: Jia Wei, et al.
Published: (2023-08-01)

The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis
by: Tongya Wang, et al.
Published: (2022-11-01)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
by: Jiao Qin, et al.
Published: (2022-01-01)

Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada
by: Philip Q. Ding, et al.
Published: (2022-12-01)

The presentation of the plague of 749/1348 and the fitna of 762/1361 by the Damascene scholar Ibn Kathîr
by: Irmeli Perho
Published: (2022-01-01)

Sustainable Biotransformation of Barley and Milk Whey for Biosufactant Production by Penicillium Sclerotiorum Ucp 1361
by: Laura Truan, et al.
Published: (2020-04-01)

Feature Review Papers on Gastroesophageal Junction and Gastric Cancers
by: Caroline Gronnier
Published: (2022-08-01)

Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
by: Lisa Paschold, et al.
Published: (2022-02-01)

Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States
by: Bradford J. Kim, et al.
Published: (2020-10-01)

Atypical presentation in adolescence of a gastroesophageal junction adenocarcinoma
by: G. Amaya Villagrán, et al.
Published: (2023-07-01)

Inguinal mass: An unusual presentation of gastroesophageal junction adenocarcinoma
by: Gourav Kaushal, et al.
Published: (2017-01-01)

Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome
by: Takeshi Okamoto, et al.
Published: (2022-01-01)

Role of tight junction proteins in gastroesophageal reflux disease
by: Mönkemüller Klaus, et al.
Published: (2012-09-01)

Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
by: Maria Angeles Gil-Delgado, et al.
Published: (2018-08-01)

Band ligation for a gastroesophageal junction Dieulafoy's lesion
by: Mohammed Amine Benatta, et al.
Published: (2017-03-01)

Synchronous Gastrointestinal Stromal Tumor and Adenocarcinoma at the Gastroesophageal Junction
by: Hui-Hua Hsiao, et al.
Published: (2009-06-01)

SEROSAL PATCH OF THE GASTROESOPHAGEAL JUNCTION: AN EXPERIMENTAL STUDY IN DOGS
by: MENDELSSONH PAULO, et al.
Published: (1998-01-01)

Survival benefit after neoadjuvant or adjuvant radiotherapy for stage II–III gastroesophageal junction adenocarcinoma: A large population-based cohort study
by: Zhichao Zuo, et al.
Published: (2022-10-01)